首页> 外国专利> CONSTRUCTION OF LIVE ATTENUATED SHIGELLA VACCINE STRAINS THAT EXPRESS CFA/I ANTIGENS (CFAB AND CFAE) AND THE B SUBUNIT OF HEAT-LABILE ENTEROTOXIN (LTB) FROM ENTEROTOXIGENIC E. COLI

CONSTRUCTION OF LIVE ATTENUATED SHIGELLA VACCINE STRAINS THAT EXPRESS CFA/I ANTIGENS (CFAB AND CFAE) AND THE B SUBUNIT OF HEAT-LABILE ENTEROTOXIN (LTB) FROM ENTEROTOXIGENIC E. COLI

机译:从肠毒素大肠杆菌中表达CFA / I抗原(CFAB和CFAE)和热肠毒素(LTB)的B亚单位的减毒志贺氏菌活菌株的构建

摘要

We have constructed a prototype vaccine strain of Shigella flexneri 2a (SC608) that can serve as a vector for the expression and delivery of heterologous antigens to the mucosal immune system. SC608 is an asd derivative of SC602, a well-characterized vaccine strain, which has recently undergone several phase 1 and 2 trials for safety and immunogenicity. Using non-antibiotic asd-based plasmids, we have created novel constructs for the expression of antigens from enterotoxigenic E. coli (ETEC), including CFA/I (CfaB and CfaE) and the B-subunit from heat-labile enterotoxin (LTB) in Shigella vaccine strain SC608. The initial experiments demonstrate the validity of a multivalent invasive Shigella strain that can serve as a vector for the delivery of pathogen-derived antigens.
机译:我们构建了弗氏志贺氏菌2a(SC608)的原型疫苗株,该菌株可作为表达载体并将异源抗原传递至粘膜免疫系统的载体。 SC608是功能齐全的疫苗株SC602的asd衍生物,最近针对安全性和免疫原性进行了多个1期和2期试验。使用基于非抗生素基于asd的质粒,我们创建了用于表达来自产肠毒素的大肠杆菌(ETEC)的抗原的新型构建体,包括CFA / I(CfaB和CfaE)和来自不耐热肠毒素(LTB)的B亚基在志贺氏菌疫苗SC608中。最初的实验证明了多价侵入性志贺氏菌菌株的有效性,该菌株可以用作递送病原体衍生抗原的载体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号